Biomerica announces Fortel Ulcer Test approved for sale by UAE Ministry

Biomerica (BMRA) announced that its Fortel Ulcer Test has been approved for sale by the United Arab Emirates, UAE, Ministry of Health and Prevention. This regulatory approval enables Biomerica to introduce its rapid point-of-care test for Helicobacter pylori infection across the UAE-a region where gastrointestinal diseases are a growing public health concern. “The Fortel Ulcer Test empowers healthcare providers to rapidly detect H. pylori infection and take timely action to prevent serious gastrointestinal diseases, including cancer,” said Zack Irani, CEO of Biomerica. “We’re proud to support the UAE’s health system with this important tool for earlier detection and better outcomes.”